Tien-Li Lee insider trades: Aardvark Therapeutics (AARD) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Tien-Li reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | AARD | ↑ Buy | 7,000 | $14.48 | $101K | Direct | Dec 12, 2025 (1d) |
| Sep 15, 2025 | AARD | ↑ Buy | 10,000 | $9.66 | $97K | Direct | Sep 16, 2025 (1d) |
| Sep 12, 2025 | AARD | ↑ Buy | 20,000 | $8.03 | $161K | Direct | Sep 12, 2025 (0d) |
| Feb 14, 2025 | AARD | ↑ Buy | 16,542 | $16.00 | $265K | Direct | Feb 19, 2025 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AARD insiders
Open-market trades in the last 12 months
About Tien-Li Lee's insider trades
Tien-Li Lee is Chief Executive Officer at Aardvark Therapeutics (AARD). Since Feb 14, 2025, Tien-Li has reported 4 open-market purchases worth $623K and no sales on SEC Form 4. In the last 12 months: 1 buy ($101K).
Their filings also include grants and awards (3 filings), option exercises (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AARD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.